Project
Glycotarget: Designing a new generation of antibody-enzyme conjugates for cancer immunotherapy through glycocalyx editing
| Reference: | UI/BD/153068/2022 |
|---|---|
| Funding organization: | Fundação para a Ciência e a Tecnologia |
| Associated institutions: | Universidade Nova de Lisboa |
Similar Items
Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)
Development of novel antibody-drug conjugated molecules for treatment of B-cell malignancies
BrainEdition: remotely controlling gene edition in neural stem cells
ArmAb: New strategy of ADC for arming antibodies in cancer therapy
Novel strategies for antibody purification through crystallization
RAtional design of canceR ImmunoTherapY: one size does not fit all
Iberian «entremezes»: inventory, edition and study
Design of iminoboronate based antitumor targeting conjugates
Cancer immunotherapy based on the adoptive transfer of Delta1 T cells
Small molecule cytokine conjugates for cancer treatment
Search of new enzymes for the oxidation of sulphur compounds.
DESIGN OF PROTEIN-IONIC LIQUID BIOMATERIALS FOR DEVELOPMENT OF A NEW GENERATION OF BIOFUELCELLS
A Small Molecule Drug Conjugate SMDC for Prostate Cancer Therapy
Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators
In vitro and in vivo studies of novel glycan-based anti-cancer Immunotherapy approaches
In vitro and in vivo studies of novel glycan-based anti-cancer Immunotherapy approaches
Structural design of third generation biomaterials
Glutamine syntethase enzymes: study of the catalitic mechanism and drug design of antibiotics and herbicides
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
BMX-targeted ligand-drug conjugates for prostate cancer therapy
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Improving the nutritional value of microalgae for feeding pigs through the use of novel enzymes
CD-ROM Edition of Portuguese Theatre of the 16th Century
Fabry disease: from iPS cells to Genomic Editing
Development of a new functional dairy product enriched in microbial bioactive conjugated fatty acids through an industrial-based approach
Novel immunotherapies for type 1 diabetes.
Dissecting regulators of anti-tumor gamma-delta T cells for improved solid cancer immunotherapy
Regulation of gamma-delta T cells in the tumor microenvironment and their manipulation towards immunotherapy of solid cancers
Quality by design-centered platform for the manufacturing of CAR-engineered NK cells and extracellular vesicles for immunotherapy
BIOMIMETIC MEMBRANES SELECTIVE FOR ANTIBODY MOLECULES
TRPV1-targeted ligand-drug conjugates to treat prostate cancer
Modulation and targeting of calcium channels with ligand-drug conjugates for cancer therapy
A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates
DISSECTING THE ROLE OF AFRICAN SWINE FEVER VIRUS ASFV UBIQUITIN-CONJUGATING E2-LIKE ENZYME AND TOPOISOMERASE TYPE II TOWARDS VACCINE DEVELOPMENT
New Extraction Processes for the Purification of Monoclonal Antibodies using Bio-inspired Ionic Liquids
Combinatorial Antibody Synthesis for the discovery of Targeted Immunomodulators
A novel tolerogenic liposome-based allergen immunotherapy for dogs in the horizon
Immobilizating enzymes for the valorization of food by-products
Targeting intracellular proteins and protein-protein interactions with site-specific lipobodies: a new approach for intracellular antibodies
Related publications
Loading publications...